Laboratory:Akiruno
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
- Oncomine DxTT Multi 6 Gene CDx (FFPE)(Suspended beyond orders placed 07-12-2024)
Laboratory:Akiruno
○Oncomine DxTT Multi 6 Gene CDx (FFPE)(Suspended beyond orders placed 07-12-2024)
CODE:00T29 0
-
TEST NAME
SPECIMEN
REQUIREMENT
(mL) CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
Oncomine DxTT Multi 6 Gene CDx (FFPE)(Suspended beyond orders placed 07-12-2024)
Unstained specimen slide
5-10 pieces 5μm
Z10
6-9 Next Generation Sequencing (NGS)A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments.
COMMENT
The purpose of this study is to analyze BRAF gene V600E mutations, EGFR gene mutation, HER2 (ERBB2) gene mutations, ALK fusion gene, ROS1 fusion gene, and RET fusion gene in genomic DNA and RNA extracted from cancer tissues to determine the indications for the drugs listed in the attached table for patients with non-small cell lung cancer.
The percentage of tumor cells required for testing is 30% or more. Please see below for notes on submitting unstained specimen slides.
Please avoid duplicate requests with other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M951 4).
●About when submitting unstained specimen slides
・The collected tissue should be immediately immersed in a 10% neutral buffered formalin solution for fixation (Recommended immobilization time is 6-48 hours). When submitting, please prepare serial sections of the 5μm thickness from formalin-fixed, paraffin-embedded blocks. Please submit the unstained slides after confirming that they contain 30% or more of tumor cells by HE stain. If the tumor cell percentage is less than 30%, mark the tumor area from the back of the unstained specimen slide. Please be aware that if the specimens are submitted without marking, it may affect the results, such as a false negative result. In addition, marked unstained specimen slides should be stored at room temperature and submitted in an object case (Z10).
・ Unstained specimen slides may not be analyzed depending on the type and composition of the fixative solution, fixation time, and storage conditions of the specimen after fixation, because nucleic acids are fragmented by formalin fixation of the tissue. Please submit samples taken within the last 3 years whenever possible. Please note that biopsy materials, in particu
CONTAINER
Z10 旧容器記号 t 30
[オブジェクトケース]
プレパラート (スライドグラス)
貯蔵方法:室温
supplementary information
オンコマインDxTTマルチ検査における対象遺伝子変異等と関連する医薬品および適応がん腫
遺伝子変異等 | がん腫 | 関連する医薬品 |
---|---|---|
BRAF 遺伝子V600E変異 | 非小細胞肺癌 | ダブラフェニブメシル酸塩及びトラメチニブジメチルスルホキシド付加物の併用投与 |
EGFR遺伝子変異 | ゲフィチニブ、エルロチニブ塩酸塩、アファチニブマレイン酸塩、オシメルチニブメシル酸塩、ダコミチニブ水和物 | |
HER2(ERBB2)遺伝子変異 | トラスツズマブ デルクステカン(遺伝子組換え) | |
ALK融合遺伝子 | クリゾチニブ、アレクチニブ塩酸塩、ブリグチニブ、ロルラチニブ | |
ROS1融合遺伝子 | クリゾチニブ、エヌトレクチニブ | |
RET融合遺伝子 | セルペルカチニブ |